NASDAQ / LIVE COMPANY INTELLIGENCE

Sana Biotechnology, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERSANA
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / SANA COVERAGE

What’s moving Sana Biotechnology, Inc. now

Current reporting with the operating signal separated from the noise.

01
PR Newswire

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Investors are testing whether Sana Biotechnology, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Sana Biotechnology, Inc: Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and ...

Sana Biotechnology, Inc: Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and ...

The story matters when it changes Sana Biotechnology, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

The story matters when it changes Sana Biotechnology, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

The story matters when it changes Sana Biotechnology, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest SANA filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-11 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-03 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-05 · Period 2026-06-04SEC ↗8-KMaterial company eventFiled 2026-05-15 · Period 2026-05-15SEC ↗8-KMaterial company eventFiled 2026-05-11 · Period 2026-05-11SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-24 · Period 2026-06-04SEC ↗4Official SEC filingFiled 2026-07-07 · Period 2026-07-06SEC ↗
EARNINGS / QUARTERLY TRACKER

Sana Biotechnology, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.